Table 3.
Correlation between the extent of TAM infiltration, MVD value, PTEN/PI3K/p-AKT expression, and clinicopathological parameters.
Variable | Cases(N) | Number of M1 TAMs | Number of M2 TAMs | Number of MVD | Expression of PTEN | Expression of PI3K | Expression of p-AKT | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
High | Low | χ2 | p | High | Low | χ2 | p | High | Low | χ2 | p | High | Low | χ2 | p | High | Low | χ2 | p | High | Low | χ2 | p | |||
Gender | ||||||||||||||||||||||||||
Male | 32 | 25 | 7 | 2.079 | 0.149 | 5 | 27 | 0.033 | 0.855 | 26 | 6 | 0.397 | 0.529 | 10 | 22 | 0.083 | 0.774 | 23 | 9 | 1.707 | 0.191 | 25 | 7 | 2.079 | 0.149 | |
Female | 17 | 16 | 1 | 3 | 14 | 15 | 2 | 6 | 11 | 15 | 2 | 16 | 1 | |||||||||||||
Age (years) | ||||||||||||||||||||||||||
<60 | 13 | 10 | 3 | 0.590 | 0.442 | 4 | 9 | 2.702 | 0.100 | 10 | 3 | 0.590 | 0.442 | 6 | 7 | 1.467 | 0.226 | 11 | 2 | 0.507 | 0.476 | 11 | 2 | 0.011 | 0.915 | |
≥60 | 36 | 31) | 5 | 4 | 32 | 31 | 5 | 10 | 26 | 27 | 9 | 30 | 6 | |||||||||||||
Tumor diameter (cm) | ||||||||||||||||||||||||||
<3 | 17 | 12 | 5 | 3.263 | 0.071 | 5 | 12 | 3.263 | 0.071 | 11 | 6 | 6.855 | 0.009* | 10 | 7 | 8.107 | 0.004* | 11 | 6 | 2.467 | 0.116 | 11 | 6 | 6.855 | 0.009* | |
≥3 | 32 | 29 | 3 | 3 | 29 | 30 | 2 | 6 | 26 | 27 | 5 | 30 | 2 | |||||||||||||
Histology grade | ||||||||||||||||||||||||||
G1–G2 | 36 | 29 | 7 | 0.966 | 0.326 | 7 | 29 | 0.966 | 0.326 | 30 | 6 | 0.011 | 0.915 | 13 | 23 | 0.738 | 0.390 | 27 | 9 | 0.507 | 0.476 | 30 | 6 | 0.011 | 0.915 | |
G3 | 13 | 12 | 1 | 1 | 12 | 11 | 2 | 3 | 10 | 11 | 2 | 11 | 2 | |||||||||||||
Depth of invasion | ||||||||||||||||||||||||||
T1–T2 | 24 | 16 | 8 | 9.959 | 0.002* | 7 | 17 | 5.677 | 0.017* | 17 | 7 | 5.677 | 0.017* | 13 | 11 | 9.900 | 0.002* | 14 | 10 | 9.979 | 0.002* | 16 | 8 | 9.959 | 0.002* | |
T3–T4 | 25 | 25 | 0 | 1 | 24 | 24 | 1 | 3 | 22 | 24 | 1 | 25 | 0 | |||||||||||||
Lymph node status | ||||||||||||||||||||||||||
N− | 32 | 24 | 8 | 5.079 | 0.038* | 8 | 24 | 5.079 | 0.038* | 24 | 8 | 5.079 | 0.038* | 15 | 17 | 8.483 | 0.004* | 22 | 10 | 4.104 | 0.043* | 24 | 8 | 5.079 | 0.038* | |
N+ | 17 | 17 | 0 | 0 | 17 | 17 | 0 | 1 | 16 | 16 | 1 | 17 | 0 | |||||||||||||
Pathological stage | ||||||||||||||||||||||||||
I-II | 32 | 24 | 8 | 5.079 | 0.038* | 8 | 24 | 5.079 | 0.038* | 24 | 8 | 5.079 | 0.038* | 15 | 17 | 8.483 | 0.004* | 22 | 10 | 4.104 | 0.043* | 24 | 8 | 5.079 | 0.038* | |
III-IV | 17 | 17 | 0 | 0 | 17 | 17 | 0 | 1 | 16 | 16 | 1 | 17 | 0 |
N+, Lymph node metastasis; N−, No lymph node metastasis; MVD, Microvessel density. *p < 0.05.